Lai and co-authors created IL-12-LNP nanoparticles loaded with mRNA of interleukin-12 (IL-12) for the in situ delivery of this cargo in a primary transgenic mouse model of refractory MYC-driven hepatocellular carcinoma [235]. Here, MYC is linked to hepatocellular carcinoma.